Enhanced therapeutic effects for human pancreatic cancer by application K-ras and IGF-IR antisense oligodeoxynucleotides

doi:10.3748/wjg.14.5176

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 33

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3098)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-1) series.

Item

Count

PDF

254

HTML

2439

Figures (1-7)

209

Tables (1-1)

196

Sum=3098

Sep 7, 2008 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Sep 7, 2008; 14(33): 5176-5185
Published online Sep 7, 2008. doi: 10.3748/wjg.14.5176

Full Size Figure Download Figure

Figure 1 Detection of K-ras point mutation at 12 codon and its style in pancreatic cancer cell line Patu8988 by PCR-SSP. 1: β-actin; 2: R1-R4 pairing (CGT mutation); 3: R2-R4 pairing (GTT mutation); 4: R3-R4 pairing (GAT mutation); M: 100 bp DNA marker.

Citation: Shen YM, Yang XC, Yang C, Shen JK. Enhanced therapeutic effects for human pancreatic cancer by application K-ras and IGF-IR antisense oligodeoxynucleotides. World J Gastroenterol 2008; 14(33): 5176-5185
URL: https://www.wjgnet.com/1007-9327/full/v14/i33/5176.htm
DOI: https://dx.doi.org/10.3748/wjg.14.5176